Workflow
In vitro diagnostics solutions
icon
Search documents
QuidelOrtho Completes Debt Refinancing
Prnewswireยท 2025-08-21 20:30
Core Viewpoint - QuidelOrtho Corporation has successfully completed a series of transactions to refinance its debt structure, extending debt maturities and reducing required amortization payments, which supports future growth [1][3]. Summary of New Transactions - The company has secured a $1.15 billion 5-year senior secured Term Loan A, replacing the previous Term Loan A from 2022 [8]. - A $100 million delayed draw Term Loan A has been established, which remains undrawn at the close [8]. - Additionally, a $1.45 billion 7-year senior secured Term Loan B has been arranged [8]. - The refinancing includes a $700 million revolving credit facility that replaces and pays in full the previous credit facility [8]. Financial Strategy - The Chief Financial Officer emphasized that the highest capital allocation priority is to reduce total debt and net debt leverage, improving financial flexibility and cash flow [3]. - The improved debt covenant terms and reduced amortization requirements will provide greater options for funding continued business growth [3].